In vivo perturbomics identifies CALHM2 as a checkpoint of NK cell therapy
RNA-seq (gene expression) · human · 109 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 109 samples: 101 distinct titles, 4 of them repeatedGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- In vivo AAV-SB-CRISPR screens of tumor-infiltrating primary NK cells identify genetic checkpoints of CAR-NK therapyNature biotechnology · 2025
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE262709_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1093034 and SRA study SRP498533. Searching any of these in the dataset finder brings you back here.
Supports a case/control comparison: 41 samples read as cases, 8 as controls.
How we read this: Read from 109 sample titles: 101 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8174065 Unstim_AAVS1_1
- GSM8174066 Unstim_AAVS1_2
- GSM8174067 Unstim_AAVS1_3
- GSM8174068 Unstim_CALHM2_1
- GSM8174069 Unstim_CALHM2_2
- GSM8174070 Unstim_CALHM2_3
- GSM8174071 Stim_AAVS1_1
- GSM8174072 Stim_AAVS1_2
- GSM8174073 Stim_AAVS1_3
- GSM8174074 Stim_CALHM2_1
- GSM8174075 Stim_CALHM2_2
- GSM8174076 Stim_CALHM2_3
- GSM8174077 B16F10_m1_Tumor
- GSM8174078 B16F10_m1_Spleen
- GSM8174079 B16F10_m2_Tumor
- GSM8174080 B16F10_m2_Spleen
- GSM8174081 B16F10_m3_Tumor
- GSM8174082 B16F10_m3_Spleen
- GSM8174083 B16F10_m4_Tumor
- GSM8174084 B16F10_m4_Spleen
- GSM8174085 B16F10_m5_Tumor
- GSM8174086 B16F10_m5_Spleen
- GSM8174087 B16F10_m6_Tumor
- GSM8174088 B16F10_m6_Spleen
- GSM8174089 B16F10_m7_Tumor
- GSM8174090 B16F10_m7_Spleen
- GSM8174091 B16F10_m8_Tumor
- GSM8174092 B16F10_m8_Spleen
- GSM8174093 B16F10_m9_Tumor
- GSM8174094 B16F10_m9_Spleen
- GSM8174095 B16F10_m10_Spleen
- GSM8174096 B16F10_m11_Spleen
- GSM8174097 E0771_m1_Tumor
- GSM8174098 E0771_m1_Spleen
- GSM8174099 E0771_m2_Tumor
- GSM8174100 E0771_m2_Spleen
- GSM8174101 E0771_m3_Tumor
- GSM8174102 E0771_m3_Spleen
- GSM8174103 E0771_m4_Tumor
- GSM8174104 E0771_m4_Spleen
+ 69 more — browse all 109 samples with per-sample file links →
- GSE335904 In Vivo CRISPR Screens Identify SLC1A5 as a Metabolic Checkpoint for Cancer Immunotherapy [ATAC] 4 samples shares checkpoint, therapy, vivo
- GSE235233 Senescent cancer-associated fibroblasts in pancreatic adenocarcinoma suppress CD8+ T cell activation and inhibit response to immune checkpoint therapy [Cultured_Human_Mouse] 16 samples shares checkpoint, therapy
- GSE180045 Identification of Pathogenic Immune Cell Subsets in Checkpoint Inhibitor-induced Myocarditis 65 samples shares checkpoint
- GSE246318 Decoding the immune checkpoint signatures in human atherosclerosis: implications of type 2 diabetes and lipid-lowering intervention 49 samples shares checkpoint
- GSE266919 Distinct Cellular Mechanisms Underlie Chemotherapies and Their Combinations with PD-L1 Checkpoint Inhibitor in Triple-Negative Breast Cancer [TNBC] 117 samples shares checkpoint
- GSE292425 Metabolic Atlas of Early Human Cortex Identifies Regulators of Cell Fate Transitions 42 samples shares identifies
- GSE240603 An eRNA Transcription Checkpoint For Diverse Signal-dependent Enhancer Activation Programs 144 samples shares checkpoint
- GSE319486 Histone methyl-transferase G9a inhibition boosts the efficacy of immune checkpoint inhibitors in experimental hepatocellular carcinoma 18 samples shares checkpoint
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.